Catalyst Wire Dossier Catalyst Wire Dossier

Shigella4V2 vaccine

Shigella bioconjugate vaccine · LimmaTech Biologics AG
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Shigella4V2 vaccine, covering 2026-02-09 to 2026-02-09. Get the full timeline:

Most recent: Clinical Trial Update: Study to Expand Safety and Immunogenicity Data With Shigella Bioconjugate Vaccine (Shigella4V2) in 9-month-old Infants. [Phase 2]

See pricing